{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T11:46:01Z","timestamp":1775389561259,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU23-08-00229"],"award-info":[{"award-number":["NU23-08-00229"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010653","name":"Masaryk University","doi-asserted-by":"publisher","award":["MUNI\/A\/1676\/2024"],"award-info":[{"award-number":["MUNI\/A\/1676\/2024"]}],"id":[{"id":"10.13039\/501100010653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010653","name":"Masaryk University","doi-asserted-by":"publisher","award":["MUNI\/A\/1684\/2024"],"award-info":[{"award-number":["MUNI\/A\/1684\/2024"]}],"id":[{"id":"10.13039\/501100010653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010653","name":"Masaryk University","doi-asserted-by":"publisher","award":["MUNI\/A\/1722\/2024"],"award-info":[{"award-number":["MUNI\/A\/1722\/2024"]}],"id":[{"id":"10.13039\/501100010653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jchromb.2026.124929","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:46:17Z","timestamp":1768549577000},"page":"124929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Toward needle-free lamotrigine monitoring: Proof-of-concept for saliva and dried saliva spot analysis by LC-MS\/MS - a short communication"],"prefix":"10.1016","volume":"1271","author":[{"given":"Vikt\u00f3ria","family":"\u010eur\u010dov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Pelcov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"\u0160mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Str\u00fd\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Gregorov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Pe\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zden\u011bk","family":"Glatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"\u0160i\u0161t\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Ju\u0159ica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.124929_bb0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jpha.2021.11.001","article-title":"Potential use of a dried saliva spot (DSS) in therapeutic drug monitoring and disease diagnosis","volume":"12","author":"Han","year":"2022","journal-title":"J. Pharmaceutical Anal."},{"key":"10.1016\/j.jchromb.2026.124929_bb0010","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.tibtech.2020.03.001","article-title":"On-site therapeutic drug monitoring","volume":"38","author":"Ates","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jchromb.2026.124929_bb0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1528-1167.2007.01274.x","article-title":"Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (the COMPASS study)","volume":"49","author":"Tompson","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jchromb.2026.124929_bb0020","unstructured":"UpToDate, W., MA. Inc, Lamotrigine: Drug information (2024). https:\/\/www.uptodate.com\/contents\/lamotrigine-drug-information."},{"key":"10.1016\/j.jchromb.2026.124929_bb0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1055\/s-0031-1296641","article-title":"Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers","volume":"57","author":"Incecayir","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jchromb.2026.124929_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jchromb.2017.11.040","article-title":"A simple, rapid and stability indicating validated method for quantification of lamotrigine in human plasma and dry plasma spot using LC-ESI\u2013MS\/MS: application in clinical study","volume":"1072","author":"Namdev","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.124929_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122750","article-title":"High performance liquid chromatography: a versatile tool for assaying antiepileptic drugs in biological matrices","volume":"1179","author":"Opuni","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.124929_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jchromb.2014.09.010","article-title":"Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine","volume":"971","author":"Ferreira","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.124929_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchromb.2017.11.005","article-title":"Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation","volume":"1072","author":"Linder","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.124929_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jchromb.2026.124929_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jat\/bky064","article-title":"Determination of antiepileptic drugs using dried saliva spots","volume":"43","author":"Carvalho","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2026.124929_bb0060","series-title":"Bioanalytical Method Validation and Study Sample Analysis M10, ICH Harmonised Guideline, Geneva, Switzerland","author":"Guideline","year":"2022"},{"key":"10.1016\/j.jchromb.2026.124929_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110595","article-title":"Is the salivary concentration of lamotrigine and levetiracetam associated with clinical outcome?","volume":"171","author":"Vassallo","year":"2025","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jchromb.2026.124929_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116877","article-title":"Non-invasive therapeutic drug monitoring: LC-MS validation for lamotrigine quantification in dried blood spot and oral fluid\/saliva","volume":"262","author":"Pelcov\u00e1","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.124929_bb0075","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4155\/bio.13.214","article-title":"Recent advances in the bioanalytical applications of dried matrix spotting for the analysis of drugs and their metabolites","volume":"5","author":"Zimmer","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2026.124929_bb0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/ph17040449","article-title":"An LC-MS\/MS method for quantification of lamotrigine and its Main metabolite in dried blood spots","volume":"17","author":"Milosheska","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jchromb.2026.124929_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/FTD.0000000000000600","article-title":"LC-MS\/MS-based quantification of 9 antiepileptic drugs from a dried sample spot device","volume":"41","author":"D'Urso","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2026.124929_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinbiochem.2019.09.009","article-title":"Comparison of plasma, saliva, and hair lamotrigine concentrations","volume":"74","author":"Kuczynska","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2026.124929_bb0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1055\/s-0031-1296332","article-title":"A sensitive and selective HPLC method for estimation of lamotrigine in human plasma and saliva: application to plasma-saliva correlation in epileptic patients","volume":"60","author":"Mallayasamy","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jchromb.2026.124929_bb0100","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1592\/phco.23.15.1550.31957","article-title":"Correlation of lamotrigine concentrations between serum and saliva","volume":"23","author":"Ryan","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jchromb.2026.124929_bb0105","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00007691-200010000-00003","article-title":"Saliva and serum concentration of lamotrigine in patients with epilepsy","volume":"22","author":"Tsiropoulos","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2026.124929_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.microc.2016.09.007","article-title":"Determination of lamotrigine in human plasma and saliva using microextraction by packed sorbent and high performance liquid chromatography\u2013diode array detection: an innovative bioanalytical tool for therapeutic drug monitoring","volume":"130","author":"Ventura","year":"2017","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2026.124929_bb0115","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.clinthera.2021.10.012","article-title":"Use of saliva as an alternative matrix to serum\/plasma for therapeutic drug monitoring using reverse-phase HPLC","volume":"43","author":"Ashraf","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jchromb.2026.124929_bb0120","doi-asserted-by":"crossref","DOI":"10.1007\/BF00196118","article-title":"Effect of saliva flow rate on saliva phenytoin concentrations: implications for therapeutic monitoring","volume":"46","author":"Kamali","year":"1994","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.124929_bb0125","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/clinchem\/47.10.1788","article-title":"Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH","volume":"47","author":"Navarro","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2026.124929_bb0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt1978245563","article-title":"Drug concentration in saliva","volume":"24","author":"Mueklow","year":"1978","journal-title":"Clin Pharma Therapeutics"},{"key":"10.1016\/j.jchromb.2026.124929_bb0135","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/pharmaceutics13081208","article-title":"The effect of plasma protein binding on the therapeutic monitoring of antiseizure medications","volume":"13","author":"Charlier","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T10:46:56Z","timestamp":1775386016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"alternative-id":["S1570023226000188"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.124929","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward needle-free lamotrigine monitoring: Proof-of-concept for saliva and dried saliva spot analysis by LC-MS\/MS - a short communication","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.124929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124929"}}